Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Assessment of a new insulin preparation for implanted pumps used in the treatment of type 1 diabetes.

Schaepelynck P, Riveline JP, Renard E, Hanaire H, Guerci B, Baillot-Rudoni S, Sola-Gazagnes A, Catargi B, Fontaine P, Millot L, Martin JF, Tachouaft H, Jeandidier N; EVADIAC Group..

Diabetes Technol Ther. 2014 Sep;16(9):582-9. doi: 10.1089/dia.2013.0369.

PMID:
24735100
2.

Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial.

Hermanides J, Nørgaard K, Bruttomesso D, Mathieu C, Frid A, Dayan CM, Diem P, Fermon C, Wentholt IM, Hoekstra JB, DeVries JH.

Diabet Med. 2011 Oct;28(10):1158-67. doi: 10.1111/j.1464-5491.2011.03256.x.

PMID:
21294770
3.

Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience.

Gin H, Renard E, Melki V, Boivin S, Schaepelynck-Bélicar P, Guerci B, Selam JL, Brun JM, Riveline JP, Estour B, Catargi B; EVADIAC Study Group..

Diabetes Metab. 2003 Dec;29(6):602-7.

4.

Long-term therapy of IDDM with an implantable insulin pump. The Implantable Insulin Pump Trial Study Group.

Dunn FL, Nathan DM, Scavini M, Selam JL, Wingrove TG.

Diabetes Care. 1997 Jan;20(1):59-63.

PMID:
9028695
5.

Insulin pump therapy started at the time of diagnosis: effects on glycemic control and pancreatic β-cell function in type 1 diabetes.

Thrailkill KM, Moreau CS, Swearingen C, Rettiganti M, Edwards K, Morales AE, Kemp SF, Frindik JP, Fowlkes JL.

Diabetes Technol Ther. 2011 Oct;13(10):1023-30. doi: 10.1089/dia.2011.0085.

PMID:
21718094
7.

A recent survey confirms the efficacy and the safety of implanted insulin pumps during long-term use in poorly controlled type 1 diabetes patients.

Schaepelynck P, Renard E, Jeandidier N, Hanaire H, Fermon C, Rudoni S, Catargi B, Riveline JP, Guerci B, Millot L, Martin JF, Sola A; EVADIAC Group..

Diabetes Technol Ther. 2011 Jun;13(6):657-60. doi: 10.1089/dia.2010.0209.

PMID:
21470000
8.

Application of novel dual wave meal bolus and its impact on glycated hemoglobin A1c level in children with type 1 diabetes.

Pańkowska E, Szypowska A, Lipka M, Szpotańska M, Błazik M, Groele L.

Pediatr Diabetes. 2009 Aug;10(5):298-303. doi: 10.1111/j.1399-5448.2008.00471.x.

PMID:
19175902
9.

Continuous intraperitoneal insulin infusion in type 1 diabetes: a 6-year post-trial follow-up.

van Dijk PR, Logtenberg SJ, Groenier KH, Gans RO, Kleefstra N, Bilo HJ.

BMC Endocr Disord. 2014 Apr 7;14:30. doi: 10.1186/1472-6823-14-30.

10.

ProAct study: new features of insulin pumps improve diabetes management and glycemic control in patients after transition of continuous subcutaneous insulin infusion systems.

Ziegler R, Tubili C, Chico A, Guerci B, Lundberg E, Borchert M, Löffler A, Bloethner S, Weissmann J, Pfützner A.

Diabetes Technol Ther. 2013 Sep;15(9):738-43. doi: 10.1089/dia.2013.0090.

PMID:
23931739
11.
12.
13.

Assessment of use of specific features of subcutaneous insulin infusion systems and their relationship to metabolic control in patients with type 1 diabetes.

Quirós C, Patrascioiu I, Giménez M, Vinagre I, Vidal M, Jansà M, Conget I.

Endocrinol Nutr. 2014 Jun-Jul;61(6):318-22. doi: 10.1016/j.endonu.2014.01.003. English, Spanish.

PMID:
24533929
14.

Clinical trial of programmable implantable insulin pump for type I diabetes.

Selam JL, Micossi P, Dunn FL, Nathan DM.

Diabetes Care. 1992 Jul;15(7):877-85.

PMID:
1516508
15.

Insulin pump-long-term effects on glycemic control: an observational study at 10 diabetes clinics in Sweden.

Carlsson BM, Attvall S, Clements M, Gumpeny SR, Pivodic A, Sternemalm L, Lind M.

Diabetes Technol Ther. 2013 Apr;15(4):302-7. doi: 10.1089/dia.2012.0286.

PMID:
23537418
16.

Insulin pump therapy is equally effective and safe in elderly and young type 1 diabetes patients.

Matejko B, Cyganek K, Katra B, Galicka-Latala D, Grzanka M, Malecki MT, Klupa T.

Rev Diabet Stud. 2011 Summer;8(2):254-8. doi: 10.1900/RDS.2011.8.254.

17.

Type 1 diabetes: treatment and prevention.

Hitman GA.

Diabet Med. 2011 Oct;28(10):1139. doi: 10.1111/j.1464-5491.2011.03417.x. No abstract available.

PMID:
21923695
18.

The SWITCH study (sensing with insulin pump therapy to control HbA(1c)): design and methods of a randomized controlled crossover trial on sensor-augmented insulin pump efficacy in type 1 diabetes suboptimally controlled with pump therapy.

Conget I, Battelino T, Giménez M, Gough H, Castañeda J, Bolinder J; SWITCH Study Group..

Diabetes Technol Ther. 2011 Jan;13(1):49-54. doi: 10.1089/dia.2010.0107.

PMID:
21175271
19.

Insulin pump treatment in children and adolescents with type 1 diabetes.

Hofer S, Meraner D, Koehle J.

Minerva Pediatr. 2012 Aug;64(4):433-8. Review.

PMID:
22728614
20.

Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study.

Petrovski G, Dimitrovski C, Bogoev M, Milenkovic T, Ahmeti I, Bitovska I.

Diabetes Technol Ther. 2011 Nov;13(11):1109-13. doi: 10.1089/dia.2011.0081.

PMID:
21751889

Supplemental Content

Support Center